rs934111355
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001164508.2(NEB):c.24339_24342del(p.Pro8114SerfsTer30) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000132 in 152,046 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000077 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
NEB
NM_001164508.2 frameshift
NM_001164508.2 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.46
Genes affected
NEB (HGNC:7720): (nebulin) This gene encodes nebulin, a giant protein component of the cytoskeletal matrix that coexists with the thick and thin filaments within the sarcomeres of skeletal muscle. In most vertebrates, nebulin accounts for 3 to 4% of the total myofibrillar protein. The encoded protein contains approximately 30-amino acid long modules that can be classified into 7 types and other repeated modules. Protein isoform sizes vary from 600 to 800 kD due to alternative splicing that is tissue-, species-,and developmental stage-specific. Of the 183 exons in the nebulin gene, at least 43 are alternatively spliced, although exons 143 and 144 are not found in the same transcript. Of the several thousand transcript variants predicted for nebulin, the RefSeq Project has decided to create three representative RefSeq records. Mutations in this gene are associated with recessive nemaline myopathy. [provided by RefSeq, Sep 2009]
RIF1 (HGNC:23207): (replication timing regulatory factor 1) This gene encodes a protein that shares homology with the yeast teleomere binding protein, Rap1 interacting factor 1. This protein localizes to aberrant telomeres may be involved in DNA repair. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 2-151496991-CAGGT-C is Pathogenic according to our data. Variant chr2-151496991-CAGGT-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 533968.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-151496991-CAGGT-C is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEB | NM_001164507.2 | c.24339_24342del | p.Pro8114SerfsTer30 | frameshift_variant | 172/182 | ENST00000427231.7 | NP_001157979.2 | |
NEB | NM_001164508.2 | c.24339_24342del | p.Pro8114SerfsTer30 | frameshift_variant | 172/182 | ENST00000397345.8 | NP_001157980.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEB | ENST00000397345.8 | c.24339_24342del | p.Pro8114SerfsTer30 | frameshift_variant | 172/182 | 5 | NM_001164508.2 | ENSP00000380505 | P5 | |
NEB | ENST00000427231.7 | c.24339_24342del | p.Pro8114SerfsTer30 | frameshift_variant | 172/182 | 5 | NM_001164507.2 | ENSP00000416578 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152046Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
2
AN:
152046
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000498 AC: 1AN: 200820Hom.: 0 AF XY: 0.00000933 AC XY: 1AN XY: 107132
GnomAD3 exomes
AF:
AC:
1
AN:
200820
Hom.:
AF XY:
AC XY:
1
AN XY:
107132
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000770 AC: 11AN: 1428234Hom.: 0 AF XY: 0.00000990 AC XY: 7AN XY: 707148
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
11
AN:
1428234
Hom.:
AF XY:
AC XY:
7
AN XY:
707148
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152046Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74270
GnomAD4 genome
AF:
AC:
2
AN:
152046
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
74270
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Nemaline myopathy 2 Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Jan 30, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 09, 2023 | This sequence change creates a premature translational stop signal (p.Pro8149Serfs*30) in the NEB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NEB are known to be pathogenic (PMID: 25205138). This variant is present in population databases (no rsID available, gnomAD 0.001%). This premature translational stop signal has been observed in individuals with nemaline myopathy (PMID: 25205138, 26809617). This variant is also known as c.24339_24342del, p.Leu8113Leufs. ClinVar contains an entry for this variant (Variation ID: 533968). For these reasons, this variant has been classified as Pathogenic. - |
NEB-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 06, 2024 | The NEB c.24444_24447delACCT variant is predicted to result in a frameshift and premature protein termination (p.Pro8149Serfs*30). Of note, this variant can also be referred to as c.24339_24342delACCT (p.Pro8114Serfs*30) with alternate isoform, NM_001164507. This variant has been reported in the compound heterozygous state in two individuals with nemaline myopathy (Lehtokari et al 2014. PubMed ID: 25205138; Reported as c.24339_24342del in Lévesque S et al 2016. PubMed ID: 26809617). This variant is reported in 0.0039% of alleles in individuals of South Asian descent in gnomAD. Frameshift variants in NEB are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Nemaline myopathy Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 03, 2023 | Variant summary: NEB c.24444_24447delACCT (p.Pro8149SerfsX30) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 5e-06 in 200820 control chromosomes (gnomAD). c.24444_24447delACCT, which is located in an alternatively spliced exon (Lehtokari_2014), has been reported in the literature in the compound heterozygous state in two individuals affected with nemaline myopathy who had atypical and/or late onset of symptoms (Lehtokari_2014, Levesque_2016). These data indicate that the variant is likely associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Arthrogryposis multiplex congenita 6 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Jun 29, 2023 | - - |
Nemaline myopathy 2;C5543431:Arthrogryposis multiplex congenita 6 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 18, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AL_spliceai
Position offset: 42
Find out detailed SpliceAI scores and Pangolin per-transcript scores at